.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Delivery within India

Delivery outside India

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Markets
News
Corporate
- Corporate Strategist
- Down the Ages
AI
Magazine
OB DataLens
In Depth
Economy & Policy
- Nash Equilibria
Videos
Start-Up
Planet

News
Magazine
Markets
In Depth
Economy & Policy
- Nash Equilibria
Videos
Start-Up
Planet
Corporate
- Corporate Strategist
- Down the Ages
Tech
AI
Budget 2025
Spotlight
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

Markets
News
Corporate
AI
Magazine
OB DataLens
In Depth
Economy & Policy
Videos
Start-Up
Planet

home
Topic
Cancer drug

Cancer Drug

Dr Reddys, Immutep Ink Licensing Pact for Cancer Drug

Dr Reddy's, Immutep Ink Licensing Pact for Cancer Drug

BY PTI

Zydus Lifesciences

Zydus Lifesciences Gets Tentative USFDA Nod for Generic Blood Cancer Drug

BY PTI

Drug Development

How Glenmark’s AbbVie Deal is a Masterclass in Indian Pharma's R&D Ambitions

BY Vaibhavi Ranjan

Glenmark signs landmark licensing deal

Glenmark Pharma Shares Surge 10% On Arm’s Landmark Deal with AbbVie For Cancer Drug

BY Outlook Business Desk

Sun Pharma Inks Licensing Pact With Philogen For Cancer Medication

Sun Pharma Inks Licensing Pact With Philogen For Cancer Medication

BY PTI

Glenmark Ties with BeiGene to Market Cancer Drugs

Glenmark Unit Ties Up With BeiGene To Market Cancer Drugs In India

BY PTI

Glenmark Ties with BeiGene to Market Cancer Drugs

Glenmark Unit Ties Up with BeiGene to Market Cancer Drugs in India

BY Press Trust of India

Advertisement

Dr Reddy’s Acquires Trademark Rights Of Breast Cancer Drug Primcyv From Pfizer To Use In India

Dr Reddy’s Acquires Trademark Rights Of Breast Cancer Drug Primcyv From Pfizer To Use In India

BY Press Trust of India

Close Ad

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2026 Outlook Publishing India Pvt Ltd.

Copyright © 2026 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.